Edition:
United States

Virbac SA (VIRB.PA)

VIRB.PA on Paris Stock Exchange

149.50EUR
26 May 2017
Change (% chg)

€-0.50 (-0.33%)
Prev Close
€150.00
Open
€150.75
Day's High
€150.75
Day's Low
€148.60
Volume
7,407
Avg. Vol
8,850
52-wk High
€197.95
52-wk Low
€127.00

VIRB.PA

Chart for VIRB.PA

About

Virbac SA is a France-based veterinarian pharmaceutical company that specializes in the development and production of vaccines and medicines for domestic animals and livestock. Its production centers are located in France, Australia, the United States, Mexico, Vietnam, Brazil and South Africa. Its development efforts focus... (more)

Overall

Beta: 1.07
Market Cap(Mil.): €1,264.47
Shares Outstanding(Mil.): 8.46
Dividend: --
Yield (%): --

Financials

  VIRB.PA Industry Sector
P/E (TTM): 36.38 14.27 17.41
EPS (TTM): 4.11 -- --
ROI: 3.76 -7.17 -5.42
ROE: 7.60 -6.63 -4.68

BRIEF-Virbac Q1 sales fall to 199.7 million euros

* First quarter 2017 sales down, strongly impacted by stock effects in the distribution

Apr 12 2017

BRIEF-Virbac FY operating profit 69.0 million euros, up 100 percent

* FY operating profit 69.0 million euros ($73.59 million), up 100 percent

Mar 10 2017

BRIEF-Virbac Q4 net revenue up to 225.7 million euros

* Q4 net revenue 225.7 million euros ($241.41 million) versus 206.2 million euros year ago

Jan 17 2017

More From Around the Web

Earnings vs. Estimates